Literature DB >> 19167379

Vascular wall resident progenitor cells: a review.

Annalisa Pacilli1, Gianandrea Pasquinelli.   

Abstract

The vessel wall has usually been thought to be relatively quiescent. But the discovery of progenitor cells in many tissues and in the vasculature itself has led to a reconsideration of the vascular biology. The presence of circulating endothelial and smooth muscle progenitors able to home to the injured vascular wall is a firm acquisition; less known is the notion, coming from embryonic and adult tissue studies, that stem cells able to differentiate into endothelial cells and smooth muscle cells also reside in the arterial wall. Moreover, the existence of a vasculogenic zone has recently been identified in adult human arteries; this niche-like zone is believed to act as a source of progenitors for postnatal vasculogenesis. From the literature it is already apparent that a complex interplay between circulating and resident vascular wall progenitors takes place during embryonal and postnatal life; a structural/functional disarray of these intimate stem cell compartments could hamper appropriate vascular repair, the development of vascular wall disease being the direct clinical consequence in adult life. This review gives an overview of adult large vessel progenitors established in the vascular wall during embryogenesis and their role in the maintenance of wall homeostasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19167379     DOI: 10.1016/j.yexcr.2008.12.018

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  21 in total

1.  Remodeling in vein expresses arterial phenotype in hyperhomocysteinemia.

Authors:  Poulami Basu; Natia Qipshidze; Suresh C Tyagi; Utpal Sen
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-11-15

2.  Chronic hyperhomocysteinemia causes vascular remodelling by instigating vein phenotype in artery.

Authors:  Poulami Basu; Natia Qipshidze; Utpal Sen; Srikanth Givvimani; Charu Munjal; Paras K Mishra; Suresh C Tyagi
Journal:  Arch Physiol Biochem       Date:  2011-08-13       Impact factor: 4.076

Review 3.  Adult human adipose tissue contains several types of multipotent cells.

Authors:  Tiziano Tallone; Claudio Realini; Andreas Böhmler; Christopher Kornfeld; Giuseppe Vassalli; Tiziano Moccetti; Silvana Bardelli; Gianni Soldati
Journal:  J Cardiovasc Transl Res       Date:  2011-02-15       Impact factor: 4.132

Review 4.  Multilineage stem cells in the adult: a perivascular legacy?

Authors:  Mihaela Crisan; Mirko Corselli; Chien-Wen Chen; Bruno Péault
Journal:  Organogenesis       Date:  2011-04-01       Impact factor: 2.500

Review 5.  Stem Cell Sources and Graft Material for Vascular Tissue Engineering.

Authors:  Dorothee Hielscher; Constanze Kaebisch; Benedikt Julius Valentin Braun; Kevin Gray; Edda Tobiasch
Journal:  Stem Cell Rev Rep       Date:  2018-10       Impact factor: 5.739

6.  Delivery of Polymeric Nanoparticles to Target Vascular Diseases.

Authors:  Edward Agyare; Karunyna Kandimalla
Journal:  J Biomol Res Ther       Date:  2014-01

Review 7.  Defining vascular stem cells.

Authors:  Ching-Shwun Lin; Tom F Lue
Journal:  Stem Cells Dev       Date:  2013-01-18       Impact factor: 3.272

8.  Coronary Artery Remodeling and Fibrosis With Continuous-Flow Left Ventricular Assist Device Support.

Authors:  Amrut V Ambardekar; Mary C M Weiser-Evans; Marcella Li; Suneet N Purohit; Muhammad Aftab; T Brett Reece; Karen S Moulton
Journal:  Circ Heart Fail       Date:  2018-05       Impact factor: 8.790

9.  Adventitial pericyte progenitor/mesenchymal stem cells participate in the restenotic response to arterial injury.

Authors:  Ulrich Tigges; Masanobu Komatsu; William B Stallcup
Journal:  J Vasc Res       Date:  2012-12-18       Impact factor: 1.934

10.  Phenotypic characterization and in vivo localization of human adipose-derived mesenchymal stem cells.

Authors:  Young-Joon Ryu; Tae-Jun Cho; Dong-Sup Lee; Jin-Young Choi; Jaejin Cho
Journal:  Mol Cells       Date:  2013-05-14       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.